RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
0.36%
↑ 105% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-7.64%
Historical baseline
PeriodValue
Q3 20250.36%
Q2 2025-2.78%
Q1 202567.76%
Q4 2024-188.89%
Q3 202433.37%
Q2 20249.36%
Q1 20241.15%
Q4 20231.58%
Q3 2023-24.09%
Q2 202313.63%
Q1 2023-27.54%
Q4 2022-8.08%
Q3 2022-10.69%
Q2 20226.27%
Q1 2022-14.16%
Q4 20213.87%
Q3 2021-15.77%
Q2 20212.45%
Q1 2021-29.67%
Q4 202012.96%
Q3 2020-18.12%
Q2 20205.72%
Q1 20200.58%
Q4 2019-32.54%
Q3 20196.16%
Q2 2019-15.65%
Q1 20192.57%
Q4 20188.30%
Q3 2018-25.35%
Q2 20180.33%
Q1 20180.00%